Literature DB >> 8178682

Epidemiology of psychiatric disorders in Edmonton. Obsessive-compulsive disorder.

J L Kolada1, R C Bland, S C Newman.   

Abstract

3258 randomly selected adult household residents of Edmonton were interviewed by trained lay interviewers using the Diagnostic Interview Schedule (DIS). One of the diagnostic categories studied was obsessive-compulsive disorder (OCD). The lifetime and six month prevalence rates of OCD were 2.9% and 1.6% respectively. The morbidity risk, was equal in males and females at 5.4%. The peak age of risk of onset for both sexes was from the ages of 10 to 19 and, closely followed by the decade 20-29. Obsessions were found to be more frequently experienced than compulsions. Having a lifetime diagnosis of OCD is associated with an increased likelihood of developing depression, alcohol abuse, drug abuse, phobic disorders, and antisocial personality disorder. The significance of these findings is discussed for clinical practice.

Entities:  

Mesh:

Year:  1994        PMID: 8178682

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  11 in total

1.  The relationship between anxiety disorders and substance use among adolescents in the community: specificity and gender differences.

Authors:  Ping Wu; Renee D Goodwin; Cordelia Fuller; Xinhua Liu; Jonathan S Comer; Patricia Cohen; Christina W Hoven
Journal:  J Youth Adolesc       Date:  2009-01-13

2.  The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder.

Authors:  Raşit Tükel; Handan Meteris; Ahmet Koyuncu; Alper Tecer; Olcay Yazici
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-05-12       Impact factor: 5.270

3.  Directionality of change in obsessive compulsive disorder (OCD) and suicidal ideation over six years in a naturalistic clinical sample.

Authors:  Lily A Brown; Emily Wakschal; Stefanie Russman-Block; Christina L Boisseau; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen
Journal:  J Affect Disord       Date:  2018-11-13       Impact factor: 4.839

4.  Obsessive-compulsive disorder and personality disorder: evidence from the British National Survey of Psychiatric Morbidity 2000.

Authors:  Albina R Torres; Paul Moran; Paul Bebbington; Traolach Brugha; Dinesh Bhugra; Jeremy W Coid; Michael Farrell; Rachel Jenkins; Glyn Lewis; Howard Meltzer; Martin Prince
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-09-15       Impact factor: 4.328

5.  Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness.

Authors:  Carmen P McLean; Anu Asnaani; Brett T Litz; Stefan G Hofmann
Journal:  J Psychiatr Res       Date:  2011-03-25       Impact factor: 4.791

Review 6.  Neuroimaging of cognitive brain function in paediatric obsessive compulsive disorder: a review of literature and preliminary meta-analysis.

Authors:  Silvia Brem; Tobias U Hauser; Reto Iannaccone; Daniel Brandeis; Renate Drechsler; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2012-06-08       Impact factor: 3.575

7.  Subtyping obsessive compulsive patients by depressive symptoms: a retrospective pilot study.

Authors:  L L Tynes; D K Winstead
Journal:  Psychiatr Q       Date:  1999

8.  Obsessive-compulsive disorder and anorexia nervosa in a high school athlete: a case report.

Authors:  R L Gee; N Telew
Journal:  J Athl Train       Date:  1999-10       Impact factor: 2.860

9.  Prevalence and correlates of obsessive-compulsive disorder and subthreshold obsessive-compulsive disorder among college students in Kerala, India.

Authors:  T S Jaisoorya; Y C Janardhan Reddy; B Sivasankaran Nair; Anjana Rani; Priya G Menon; M Revamma; C R Jeevan; K S Radhakrishnan; Vineetha Jose; K Thennarasu
Journal:  Indian J Psychiatry       Date:  2017 Jan-Mar       Impact factor: 1.759

10.  Prevalence of obsessive-compulsive disorder in Iran.

Authors:  Mohammad Reza Mohammadi; Ahmad Ghanizadeh; Mehdi Rahgozar; Ahmad Ali Noorbala; Haratoun Davidian; Hossein Malek Afzali; Hamid Reza Naghavi; Seyed Abbas Bagheri Yazdi; Seyed Mehdi Saberi; Bita Mesgarpour; Shahin Akhondzadeh; Javad Alaghebandrad; Mehdi Tehranidoost
Journal:  BMC Psychiatry       Date:  2004-02-14       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.